The chemical conglomerate is the second firm to license CRISPR/Cas9 from the Broad after Monsanto.
The program will provide two young scientists with funding for independent research as well as resources to help them commercialize their technology.
The gene-gene interactions research could lead to new therapies targeting cells with particular mutations, or combinations of targeted therapies.
The Croatan algorithm uses the random forest machine learning method to evaluate guide RNAs for use in CRISPR knockout experiments.
The company intends to use part of the proceeds of the offering to advance programs including one in Leber congenital amaurosis 10.
Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.
The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.
The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.
In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.